S. Nicole Et Al. , "Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)," NATURE GENETICS , vol.26, no.4, pp.480-483, 2000
Nicole, S. Et Al. 2000. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). NATURE GENETICS , vol.26, no.4 , 480-483.
Nicole, S., Davoine, C., Topaloglu, H., Cattolico, L., Barral, D., Beighton, P., ... Ben Hamida, C.(2000). Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). NATURE GENETICS , vol.26, no.4, 480-483.
Nicole, S Et Al. "Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)," NATURE GENETICS , vol.26, no.4, 480-483, 2000
Nicole, S Et Al. "Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)." NATURE GENETICS , vol.26, no.4, pp.480-483, 2000
Nicole, S. Et Al. (2000) . "Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)." NATURE GENETICS , vol.26, no.4, pp.480-483.
@article{article, author={S Nicole Et Al. }, title={Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)}, journal={NATURE GENETICS}, year=2000, pages={480-483} }